Jan 12, 2022 / 02:00PM GMT
Michael Roman Minchak - JPMorgan Chase & Co, Research Division - Analyst
Good morning, and thank you all for joining us today. My name is Michael Minchak, and I'm a member of the healthcare services equity research team here at JPMorgan. With us today for this next session is the management team from Patterson Companies. Patterson is one of the leading providers of products and technology and value-added services in the dental and animal health markets. So it's my pleasure to introduce CEO, Mark Walchirk. And we'll also have CFO, Don Zurbay, joining for the -- after the presentation for the Q&A session. So I wanted to thank both of you for joining us today. And with that, I'm going to hand it over to Mark.
Mark S. Walchirk - Patterson Companies, Inc. - CEO, President & Director
Michael, thanks, and good morning, everyone. Appreciate the opportunity to speak with all of you today. As Michael just mentioned, my name is Mark Walchirk. I'm the President and CEO of Patterson Companies. I'm excited to be here today to have the opportunity to tell you more
Patterson Companies Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot